Stay updated with breaking news from Zhuang shilihe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At least 7 provincial-level regions begin single-dose vaccination, to achieve herd immunity by year-end globaltimes.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globaltimes.cn Daily Mail and Mail on Sunday newspapers.
file7fokwivj0q9byjr4gak BEIJING, May 11. Global Times: The grave epidemic situation in India, the world s largest vaccine producer, the WHO s approval of Chinese vaccines for emergency use, lingering questions on whether the US can really deliver its promise to provide vaccines to the world, all these have led to a widely acknowledged situation that China could be a much more reliable global vaccine supplier, especially as domestic vaccine producers vowed to ramp up production to meet domestic immunity targets and overseas demand. After the WHO approved the Sinopharm vaccine for emergency use, Yang Xiaoming, chairman of Sinopharm China National Biotec Group (CNBG), said in a recent interview with Chinese media outlets that the Chinese vaccine manufacturer has been ramping up efforts to expand production capacity in the third-phase of production to 3 billion doses per year. ....
Source： 2021-05-11 18:03 The grave epidemic situation in India, the world s largest vaccine producer, the WHO s approval of Chinese vaccines for emergency use, lingering questions on whether the US can really deliver its promise to provide vaccines to the world, all these have led to a widely acknowledged situation that China could be a much more reliable global vaccine supplier, especially as domestic vaccine producers vowed to ramp up production to meet domestic immunity targets and overseas demand. After the WHO approved the Sinopharm vaccine for emergency use, Yang Xiaoming, chairman of Sinopharm China National Biotec Group (CNBG), said in a recent interview with Chinese media outlets that the Chinese vaccine manufacturer has been ramping up efforts to expand production capacity in the third-phase of production to 3 billion doses per year. ....
China fills vaccine gap left by US, India with expanded production to reach 5b doses annually Global Times reporter on society, cybersecurity, diplomatic relations and topics related to Xinjiang. Liu Caiyu and Leng Shumei Published: May 10, 2021 10:13 PM Updated: May 11, 2021 10:18 AM A nurse shows a vial of the Sinopharm vaccine at the Panadura Health Office in Kalutara District, in the outskirts of capital Colombo, Sri Lanka, on May 8, 2021. Sri Lanka s Health Ministry on Saturday began administering the Sinopharm vaccine to local nationals, soon after the World Health Organization (WHO) approved it for emergency use worldwide.(Photo: Xinhua) The grave epidemic situation in India, the world s largest vaccine producer, the WHO s approval of Chinese vaccines for emergency use, lingering questions on whether the US can really deliver its promise to provide vaccines to the world, all these have led to a widely acknowledged situation that China could be a much more r ....
Sinopharm vaccine likely to get WHO approval with condition: experts Cao Siqi and Leng Shumei Published: May 06, 2021 09:13 PM A resident of Beijing s Haidian district receives a dose of a COVID-19 vaccine at a mobile vaccination center that was created from a renovated bus. The capital city has administered more than 18 million doses as of Friday. Photo: cnsphotoAs the World Health Organization (WHO) is scheduled to announce the results of its evaluation of vaccines from Chinese producers Sinopharm and Sinovac Biotech for emergency authorization this week, the latest document uploaded by the WHO on the assessment of Sinopharm s vaccine showed that WHO experts have overall confidence in its ability to prevent COVID-19 while having low confidence on the risk of side effects for older patients. ....